Back to results
CompletedPhase 2

Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Docetaxel as Neoadjuvant Treatment of Breast Cancer Patients

NCT00129376

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Hospital Universitario Germans Trias i Pujol

Badalona, Barcelona, Spain

+5 additional locations

View on ClinicalTrials.gov
Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Docetaxel as Neoadjuvant Treatment of Breast Cancer Patients — TrialFind